ACADIA Pharmaceuticals Inc (ACAD)
16.25
-0.12
(-0.73%)
USD |
NASDAQ |
Jun 28, 16:00
16.24
0.00 (0.00%)
After-Hours: 20:00
ACADIA Pharmaceuticals Net Income (Annual): -61.29M for Dec. 31, 2023
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | -61.29M |
| December 31, 2022 | -215.98M |
| December 31, 2021 | -167.87M |
| December 31, 2020 | -281.58M |
| December 31, 2019 | -235.26M |
| December 31, 2018 | -245.19M |
| December 31, 2017 | -289.40M |
| December 31, 2016 | -271.39M |
| December 31, 2015 | -164.44M |
| December 31, 2014 | -92.48M |
| December 31, 2013 | -37.95M |
| December 31, 2012 | -20.85M |
| Date | Value |
|---|---|
| December 31, 2011 | -22.76M |
| December 31, 2010 | 15.14M |
| December 31, 2009 | -45.14M |
| December 31, 2008 | -64.24M |
| December 31, 2007 | -56.39M |
| December 31, 2006 | -45.05M |
| December 31, 2005 | -34.14M |
| December 31, 2004 | -25.92M |
| December 31, 2003 | -14.09M |
| December 31, 2002 | -12.87M |
| December 31, 2001 | -14.41M |
| December 31, 2000 | -10.19M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Annual) Range, Past 5 Years
-281.58M
Minimum
2020
-61.29M
Maximum
2023
-192.39M
Average
-215.98M
Median
2022
Net Income (Annual) Benchmarks
| Alnylam Pharmaceuticals Inc | -440.24M |
| Cassava Sciences Inc | -97.22M |
| Vertex Pharmaceuticals Inc | 3.620B |
| Cormedix Inc | -46.34M |
| Oragenics Inc | -20.66M |